BCLC Stage B Hepatocellular Carcinoma — Trials

BCLC Stage B Hepatocellular Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

17 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 33%
Top sponsor: City of Hope Medical Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (5)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04828486	Futibatinib and Pembrolizumab for Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer	completed	Phase 2	14	Mayo ClinicOTHER	1	Nov 18, 2025	clinicaltrials
NCT02940496	Pembrolizumab (MK-3475) in Hepatocellular Carcinoma	completed	Phase 2	15	M.D. Anderson Cancer CenterOTHER	1	Jul 15, 2025	clinicaltrials